{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:13:31Z","timestamp":1794287611621,"version":"4.9.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.autrev.2024.103657","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:55:15Z","timestamp":1727884515000},"page":"103657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intima media thickness of the carotid artery in primary antiphospholipid syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Tommaso","family":"Bucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Merashli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose'","family":"Delgado-Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.J.","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103657_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2019.10.042","article-title":"Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population","volume":"300","author":"Selmi","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2024.103657_bb0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1538-7836.2009.03308.x","article-title":"Atherosclerosis in thrombotic primary antiphospholipid syndrome","volume":"7","author":"Ames","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2024.103657_bb0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.thromres.2005.09.005","article-title":"Endothelial function is impaired in patients with primary antiphospholipid syndrome","volume":"118","author":"Stalc","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2024.103657_bb0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3109\/07853890.2014.959559","article-title":"Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies","volume":"46","author":"Ambrosino","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101672","article-title":"Risk of subclinical atherosclerosis in patients with antiphospholipid syndrome and subjects with antiphospholipid antibody positivity: a systematic review and meta-analysis","volume":"48","author":"Karakasis","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.autrev.2024.103657_bb0030","article-title":"7-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls","volume":"keae097","author":"Evangelatos","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103657_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41584-021-00652-9","article-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases","volume":"17","author":"Szekanecz","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103657_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S group PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.autrev.2024.103657_bb0045","author":"Wells"},{"key":"10.1016\/j.autrev.2024.103657_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.autrev.2024.103657_bb0055","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/bimj.201600034","article-title":"Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events","volume":"58","author":"Brockhaus","year":"2016","journal-title":"Biom J"},{"key":"10.1016\/j.autrev.2024.103657_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2024.103657_bb0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0895-4356(99)00204-8","article-title":"Misleading funnel plot for the detection of bias in meta-analysis","volume":"253","author":"Tang","year":"2000","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.autrev.2024.103657_bb0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2024.103657_bb0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.62.7.607","article-title":"Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome","volume":"62","author":"Medina","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103657_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00393-004-0601-8","article-title":"Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"63","author":"Roch","year":"2004","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2024.103657_bb0085","first-page":"545","article-title":"Patients with primary antiphospholipid syndrome and coronary microvascular dysfunction--a distinct clinical subset","volume":"42","author":"T\u0103n\u0103seanu","year":"2004","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0090","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","article-title":"Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"44","author":"Jim\u00e9nez","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103657_bb0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0961203307080224","article-title":"Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome","volume":"16","author":"Der","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103657_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2007.08.002","article-title":"Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding","volume":"37","author":"Belizna","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0003319708315304","article-title":"Flow-mediated arterial dilation in primary antiphospholipid syndrome","volume":"60","author":"Bilora","year":"2009","journal-title":"Angiology"},{"key":"10.1016\/j.autrev.2024.103657_bb0110","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/rheumatology\/ken349","article-title":"Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction","volume":"47","author":"Soltesz","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103657_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1538-7836.2009.03308.x","article-title":"Atherosclerosis in thrombotic primary antiphospholipid syndrome","volume":"7","author":"Ames","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2024.103657_bb0120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2009.1346","article-title":"Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome","volume":"302","author":"Charakida","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2024.103657_bb0125","series-title":"Annals of the Romanian Society for Cell Biology","first-page":"293","article-title":"Subclinical atherosclerosis in primary antiphospholipid syndrome","volume":"15","author":"Caraba","year":"2010"},{"key":"10.1016\/j.autrev.2024.103657_bb0130","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/art.38785","article-title":"Role of toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome","volume":"66","author":"Benhamou","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0135","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.thromres.2014.07.042","article-title":"Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome","volume":"134","author":"Asztabski","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2024.103657_bb0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/ATVBAHA.113.302680","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on \u03b22GPI-specific T cell response","volume":"34","author":"Conti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2024.103657_bb0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0961203315617841","article-title":"Primary antiphospholipid syndrome: absence of premature atherosclerosis in patients without traditional coronary artery disease risk factors","volume":"25","author":"Andrade","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103657_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejr.2016.07.001","article-title":"Serum tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and leptin as biomarkers of accelerated atherosclerosis in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"39","author":"Badawi","year":"2017","journal-title":"Egyptian Rheumatol"},{"key":"10.1016\/j.autrev.2024.103657_bb0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.semarthrit.2017.10.015","article-title":"Carotid and femoral atherosclerosis in antiphospholipid syndrome: equivalent risk with diabetes mellitus in a case-control study","volume":"47","author":"Kravvariti","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0160","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.dib.2018.06.083","article-title":"Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies","volume":"19","author":"Di Minno","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.autrev.2024.103657_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0961203319897958","article-title":"New insights into antiphospholipid-related endothelial dysfunction by assessment of vascular glycocalyx layer: results from a preliminary cross-sectional study","volume":"29","author":"Miranda","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103657_bb0170","series-title":"Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid","author":"Tektonidou","year":"2024"},{"key":"10.1016\/j.autrev.2024.103657_bb0175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.dib.2018.06.083","article-title":"Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies","volume":"19","author":"Di Minno","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.autrev.2024.103657_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268716","article-title":"Regional and demographic variations of carotid artery intima and media thickness (CIMT): a systematic review and meta-analysis","volume":"17","author":"Abeysuriya","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2024.103657_bb0185","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/eurheartj\/ehab756","article-title":"Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease","volume":"43","author":"Gasbarrino","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2024.103657_bb0190","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/rheumatology\/ken382","article-title":"Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease?","volume":"47","author":"Ames","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103657_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jvsv.2015.04.005","article-title":"Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis","volume":"3","author":"Rabinovich","year":"2015","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.autrev.2024.103657_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1076029616670259","article-title":"Subjects with a history of idiopathic deep venous thrombosis have long-term increased levels of inflammatory markers and markers of endothelial damage","volume":"23","author":"Jezovnik","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.autrev.2024.103657_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11739-019-02238-6","article-title":"Is there a link between venous and arterial thrombosis? A reappraisal","volume":"15","author":"Prandoni","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0210","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.5551\/jat.63924","article-title":"Mendelian randomization study does not support a bidirectional link between atherosclerosis and venous thromboembolism","volume":"30","author":"Hu","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.autrev.2024.103657_bb0215","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/bmj.328.7451.1279-c","article-title":"European guidelines on hypertension more flexible than those in United States","volume":"328","author":"Tanne","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2024.103657_bb0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2021.12.001","article-title":"Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study","volume":"209","author":"Bucci","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2024.103657_bb0225","article-title":"Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease","volume":"23","author":"Mungu\u00eda-Realpozo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103657_bb0230","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1182\/blood.V78.11.2894.2894","article-title":"Imbalance of thromboxane\/prostacyclin biosynthesis in patients with lupus anticoagulant","volume":"78","author":"Lellouche","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2024.103657_bb0235","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3899\/jrheum.100494","article-title":"Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome","volume":"37","author":"Ames","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103657_bb0240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2023.10.006","article-title":"ATHERO-APS study group. Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study","volume":"231","author":"Bucci","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2024.103657_bb0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0090-6980(99)00010-6","article-title":"The binding of apolipoprotein H (beta-2-glycoprotein I) to lipoproteins","volume":"57","author":"Gambino","year":"1999","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.autrev.2024.103657_bb0250","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/art.20630","article-title":"Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?","volume":"50","author":"de Carvalho","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0255","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0961203309357765","article-title":"High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome","volume":"19","author":"Ames","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103657_bb0260","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.10542","article-title":"Antibodies to high-density lipoprotein and beta-2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"46","author":"Delgado Alves","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fmed.2019.00211","article-title":"IgG anti-high-density lipoproteins antibodies discriminate between arterial and venous events in thrombotic antiphospholipid syndrome patients","volume":"6","author":"Sciascia","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0270","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-2275(20)31631-X","article-title":"A specific ligand for beta-(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages","volume":"42","author":"Kobayashi","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2024.103657_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1023651","article-title":"Oxidized low-density lipprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: a systematic review and meta-analysis","volume":"9","author":"Hong","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0280","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.semarthrit.2020.08.012","article-title":"Antiphospholipid antibodies and lower extremity peripheral artery disease: a systematic review and meta-analysis","volume":"50","author":"Merashli","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0285","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41440-019-0363-y","article-title":"Impact of cigarette smoking on nitric oxide-sensitive and nitric oxide-insensitive soluble guanylate cyclase-mediated vascular tone regulation","volume":"43","author":"Tawa","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.autrev.2024.103657_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2009.12.010","article-title":"Acrolein consumption induces systemic dyslipidemia and lipoprotein modification","volume":"243","author":"Conklin","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.autrev.2024.103657_bb0295","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1289\/ehp.1103745","article-title":"Smoking, COPD, and 3-nitrotyrosine levels of plasma proteins","volume":"119","author":"Jin","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.autrev.2024.103657_bb0300","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/rheumatology\/kead498","article-title":"Effect of smoking on thrombotic antiphospholipid syndrome: a 10-year prospective cohort study","volume":"63","author":"Jiang","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103657_bb0305","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023704","article-title":"Racial and ethnic differences in the association between classical cardiovascular risk factors and common carotid intima-media thickness: an individual participant data meta-analysis","volume":"11","author":"Nonterah","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2024.103657_bb0310","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/ATVBAHA.122.317255","article-title":"Genome-wide association study on carotid intima-media thickness identified new risk loci that shares genetic risk with cardiovascular diseases","volume":"42","author":"Tcheandjieu","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2024.103657_bb0315","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.21037\/atm-20-7197","article-title":"New insight into biology, molecular diagnostics and treatment options of unstable carotid atherosclerotic plaque: a narrative review","volume":"9","author":"Migdalski","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0320","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103657_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102821","article-title":"Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review and meta-analysis","volume":"20","author":"Merashli","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103657_bb0330","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3390\/cells11233843","article-title":"The role of oxidative stress in atherosclerosis","volume":"11","author":"Batty","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2024.103657_bb0335","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103657_bb0340","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/annrheumdis-2013-204600","article-title":"Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus","volume":"74","author":"Perez-Sanchez","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103657_bb0345","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/ATVBAHA.120.315346","article-title":"Characterization of antiphospholipid syndrome atherothrombotic risk by unsupervised integrated transcriptomic analyses","volume":"41","author":"P\u00e9rez-S\u00e1nchez","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2024.103657_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/phrs.2023.1605454","article-title":"A 7-step guideline for qualitative synthesis and Meta-analysis of observational studies in health sciences","volume":"44","author":"Glisic","year":"2023","journal-title":"Public Health Rev"},{"key":"10.1016\/j.autrev.2024.103657_bb0355","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/rheumatology\/kead292","article-title":"Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry","volume":"63","author":"Balbi","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103657_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003326","article-title":"Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome","volume":"9","author":"Drosos","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2024.103657_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.871011","article-title":"Risk factors and outcomes of acute myocardial infarction in a cohort of antiphospholipid syndrome","volume":"9","author":"Gan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0370","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/rheumatology\/keab410","article-title":"Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome","volume":"61","author":"Kwon","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103657_bb0375","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/dc11-1333","article-title":"Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes","volume":"35","author":"Yoshida","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2024.103657_bb0380","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00125-013-2898-9","article-title":"Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative","volume":"56","author":"den Ruijter","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2024.103657_bb0385","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2017.05.023","article-title":"IMPROVE study group. Carotid plaque-thickness and common carotid IMT show additive value in cardiovascular risk prediction and reclassification","volume":"263","author":"Amato","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2024.103657_bb0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10787-022-01077-w","article-title":"Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases","volume":"31","author":"Lashgari","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.autrev.2024.103657_bb0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0400","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.39791","article-title":"Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103112","article-title":"mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency","volume":"140","author":"Winans","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103657_bb0410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/ijp.IJP_215_20","article-title":"A prospective study to assess the role of paraoxonase 1 genotype and phenotype on the lipid-lowering and antioxidant activity of statins","volume":"55","author":"Godbole","year":"2023","journal-title":"Indian J Pharm"},{"key":"10.1016\/j.autrev.2024.103657_bb0415","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1160\/TH14-07-0628","article-title":"Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome","volume":"113","author":"M\u00fcller-Calleja","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2024.103657_bb0420","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2024.103657_bb0425","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/jcm11051313","article-title":"Antioxidant effects of statins by modulating Nrf2 and Nrf2\/HO-1 signalling in different diseases","volume":"11","author":"Mansouri","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2024.103657_bb0430","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103657_bb0435","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/ard.2010.135525","article-title":"Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome","volume":"70","author":"L\u00f3pez-Pedrera","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103657_bb0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2013.04.025","article-title":"Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders","volume":"711","author":"Mahalwar","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2024.103657_bb0445","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.3390\/molecules27155036","article-title":"Why ortho-and para-hydroxy metabolites can scavenge free radicals that the parent atorvastatin cannot? Important pharmacologic insight from quantum chemistry","volume":"27","author":"B\u00e2ldea","year":"2022","journal-title":"Molecules"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T16:10:29Z","timestamp":1731255029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":89,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1568997224001484"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103657","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intima media thickness of the carotid artery in primary antiphospholipid syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103657"}}